Yearly liver scans for primary sclerosing cholangitis
Part of Digestive system clinical trials.
This study tests whether yearly MRI scans of the liver (called Multiscan and MRCP+) can help monitor primary sclerosing cholangitis (a liver disease) and detect problems early. If you join, you'd get these special scans to track your liver health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of primary sclerosing cholangitis (PSC, a liver disease) from a doctor.
- You must be at least 18 years old.
- You must be able to understand and agree to participate in the study (give informed consent).
- You cannot have had a liver transplant.
- You must be able to have MRI scans, which means no severe allergic reactions to the contrast dye, no metal implants that are not safe for MRI, and no extreme claustrophobia that would make the scan impossible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what drives primary sclerosing cholangitis (PSC) and how it affects the body, using a team approach and medical tests like scans and blood work. It may help researchers understand PSC better and could improve future treatment decisions.
This study follows children and young adults with primary sclerosing cholangitis (PSC) to understand the condition and how it shows up on scans or biopsy. It may help doctors better recognize PSC and choose the best next steps for care.
This study uses MRI scans to find “biomarkers,” or imaging clues, that may help predict how autoimmune liver conditions will progress in children and young adults. If you qualify, you may get MRI imaging to see whether it relates to future health outcomes.
This study creates a national database for people diagnosed with primary sclerosing cholangitis (PSC). It may help researchers learn more about the condition by collecting health information from participants.
This study collects bile and uses it to grow small lab models (organoids) from people with primary sclerosing cholangitis (PSC) and from people without PSC. Researchers want to better understand how PSC changes bile cells, which could improve future diagnosis or treatments.
This study collects and stores samples from people with PSC (primary sclerosing cholangitis), PBC (primary biliary cholangitis), and some related liver conditions. Researchers use these samples to better understand these diseases and support future research.
Hear when a new Primary Sclerosing Cholangitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.